161 related articles for article (PubMed ID: 19000585)
1. Adverse drug reactions in patients with cardiovascular disease. Foreword.
Rahimtoola SH
Curr Probl Cardiol; 2008 Dec; 33(12):701. PubMed ID: 19000585
[No Abstract] [Full Text] [Related]
2. Adverse drug reactions in patients with cardiovascular disease.
Faulx MD; Francis GS
Curr Probl Cardiol; 2008 Dec; 33(12):703-68. PubMed ID: 19000586
[TBL] [Abstract][Full Text] [Related]
3. Adverse dermatologic effects of cardiovascular drug therapy.
Brosnan BD; Frishman WH; Sun DK; Grossman M
Heart Dis; 2000; 2(3):220-47. PubMed ID: 11728264
[TBL] [Abstract][Full Text] [Related]
4. Adverse drug reactions induced by cardiovascular drugs in cardiovascular care unit patients.
Mohebbi N; Shalviri G; Salarifar M; Salamzadeh J; Gholami K
Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):889-94. PubMed ID: 20146242
[TBL] [Abstract][Full Text] [Related]
5. [Drug therapy in advanced age].
Scholz H
Med Monatsschr Pharm; 1996 May; 19(5):132-9. PubMed ID: 8684309
[No Abstract] [Full Text] [Related]
6. Cardiovascular medications.
Williams S; Wynn G; Cozza K; Sandson NB
Psychosomatics; 2007; 48(6):537-47. PubMed ID: 18071104
[No Abstract] [Full Text] [Related]
7. [Drug therapy of cardiovascular diseases in the elderly].
Kuprash LP
Med Sestra; 1983 Jan; 42(1):23-6. PubMed ID: 6550159
[No Abstract] [Full Text] [Related]
8. [The efficacy and safety of the drug treatment of cardiovascular diseases].
Mazur NA
Ter Arkh; 1993; 65(8):4-7. PubMed ID: 8211800
[No Abstract] [Full Text] [Related]
9. Cardiology drug update. Foreword.
Crawford MH
Cardiol Clin; 2008 Nov; 26(4):xi. PubMed ID: 18929226
[No Abstract] [Full Text] [Related]
10. Impact of medical interventions on quality of life in cardiovascular disease: a consensus viewpoint.
Arnold JM; Sasson Z; Mathias S; Black WR; Gill JB; Higginson L; Huckell V; Klinke P; MacDonald R; Morgan C; Smith E; Tasch RF; Warnica W
Can J Cardiol; 1997 Mar; 13(3):235-6. PubMed ID: 9117910
[No Abstract] [Full Text] [Related]
11. [Drug-induced vital disorders].
Erdmann E
Internist (Berl); 1987 Feb; 28(2):116-22. PubMed ID: 3330064
[No Abstract] [Full Text] [Related]
12. [Ophthalmological manifestations of the side effects of cardiovascular drugs].
Mozherenkov VP; Kalashev II
Vestn Oftalmol; 1987; 103(6):58-60. PubMed ID: 3328385
[No Abstract] [Full Text] [Related]
13. Reviewing common cardiovascular drugs.
Nursing; 2002 Mar; 32(3):56-7. PubMed ID: 11902048
[No Abstract] [Full Text] [Related]
14. Hypothyroidism and cardiovascular disease.
Nichols N
Can J Cardiovasc Nurs; 2005; 15(4):68-73; quiz 73, 68. PubMed ID: 16350391
[No Abstract] [Full Text] [Related]
15. The newest critical care drugs.
Chase SL
RN; 1999 May; 62(5):34-9; quiz 40. PubMed ID: 10418524
[No Abstract] [Full Text] [Related]
16. Reporting of adverse drug reactions due to cardiovascular drugs in India: A national duty.
Kalaiselvan V; Kaur I; Kumar V; Singh GN
Indian Heart J; 2015; 67(6):613-5. PubMed ID: 26702702
[No Abstract] [Full Text] [Related]
17. Cardiovascular pharmacotherapy in older people: challenges posed by cardiovascular drug prescription in the elderly.
Kaski JC; Tamargo J; Savarese G
Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):277-279. PubMed ID: 32687147
[No Abstract] [Full Text] [Related]
18. Translating molecular target into drug therapy in cardiovascular disease.
Bril A; Avkiran M
Curr Opin Pharmacol; 2008 Apr; 8(2):111-3. PubMed ID: 18294914
[No Abstract] [Full Text] [Related]
19. Use of cardiovascular medications in the elderly.
Ali Raza J; Movahed A
Int J Cardiol; 2002 Oct; 85(2-3):203-15. PubMed ID: 12208585
[TBL] [Abstract][Full Text] [Related]
20. Generic substitution--is it safe in patients at high cardiovascular risk?
Maartens G; Blockman M; Naicker V; Blockman T; Dyer R
S Afr Med J; 2002 Nov; 92(11):837-8. PubMed ID: 12506573
[No Abstract] [Full Text] [Related]
[Next] [New Search]
